Interferon‐γ sensitizes osteosarcoma cells to fas‐induced apoptosis by up‐regulating fas receptors and caspase‐8
Authors:
- Hiroto InabaHIHiroto Inaba
- Yaddanapudi RavindranathYRYaddanapudi Ravindranath
- 17 August 2004
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 43 (7) , 729-736
Abstract
Background: Osteosarcoma is the third most frequent neoplasm in adolescents. Although chemotherapy, frequently used in pre‐ and post‐operative settings, has resulted in significant improvement in disease‐free survival, some patients show little sensitivity to chemotherapy and alternative therapeutic strategies are needed. Because the Fas ligand/Fas receptor (CD95, APO‐1) apoptosis pathway is a potential therapeutic target in osteosarcomas, we examined the effect of IFN‐γ on Fas‐induced apoptosis in four osteosarcoma cell lines.Procedure and Results: As measured by flow cytometry, all cell lines expressed cell surface IFN‐γ receptors, and when cultured for 2 days in the presence of IFN‐γ, all cell lines exhibited a significant increase in expression of Fas receptors. By flow cytometric detection of intracellular fragmented DNA as a marker of apoptosis, all cell lines cultured with either IFN‐γ or anti‐Fas antibody (clone CH‐11) alone showed only moderate apoptosis, whereas significantly high levels of apoptosis occurred in cells cultured with both IFN‐γ and CH‐11. Western blotting analysis also revealed that IFN‐γ caused up‐regulation of caspase‐8 in all cell lines, but no change in Fas‐associated death domain protein (FADD/MORT1) or caspase‐3. Both caspase‐8 and caspase‐3 were activated when apoptosis was induced with both IFN‐γ and CH‐11. Addition to cultures of z‐IETD‐fmk, an inhibitor of caspase‐8, significantly blocked this apoptosis.Conclusions: IFN‐γ sensitizes osteosarcoma cells to Fas‐induced apoptosis through up‐regulation of Fas receptor and caspase‐8. Combined immunotherapy with IFN‐γ and either anti‐Fas monoclonal antibody or cytotoxic T cells that bear Fas ligand might be a useful adjunctive therapy for patients with osteosarcoma.Keywords
This publication has 36 references indexed in Scilit:
- IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathwayOncogene, 2002
- Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuitCell Death & Differentiation, 1999
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosisCell, 1995
- Combination Therapy with Ifosfamide and Liposome-Encapsulated Muramyl TripeptideJournal of Immunotherapy, 1995
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.Journal of Experimental Medicine, 1995
- Long-Term Adjuvant Interferon Treatment of Human Osteosarcoma: A pilot studyActa Oncologica, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Incidence of malignant tumors in U.S. childrenThe Journal of Pediatrics, 1975